Star Sports Medicine Co., Ltd. filed its monthly return for the period ended 31 July 2026, indicating no movement in authorised or issued share capital during the month.

Authorised/registered capital remained at 54.83 million ordinary H-shares with a par value of RMB 1 each, representing total registered share capital of RMB 54.83 million.

Issued share capital was unchanged at 54.83 million shares, and the company reported zero treasury shares. Consequently, the total number of issued shares outstanding also stood at 54.83 million.

The filing confirmed that the public float satisfied the Main Board’s 25% minimum threshold as of month-end, ensuring continued compliance with Hong Kong Stock Exchange listing requirements.

No share options, warrants, convertible securities, or other equity-linked instruments were issued, exercised, or cancelled during the month, and there were no repurchases or other share movements reported.

All necessary confirmations regarding regulatory compliance, receipt of proceeds, and documentation were provided and signed by Joint Company Secretary Liang Xiaodan on 3 August 2026.